Literature DB >> 18284815

Neuroprotective effects of breviscapine against apoptosis induced by transient focal cerebral ischaemia in rats.

Liu Yiming1, He Wei, Lin Aihua, Zeng Fandian.   

Abstract

Breviscapine, a flavonoid isolated from the traditional Chinese medicinal herb Erigerin breviscapus, has been proved to be effective in protecting the brain against ischaemic damage, but the mechanisms remain unknown. In this study, we have demonstrated the effects of breviscapine on neuronal apoptosis in a rat model of transient focal cerebral ischaemia. Rats were administered with breviscapine (50 or 100 mg kg(-1)/day) intragastrically for seven successive days, then subjected to 2-h brain ischaemia induced by middle cerebral artery occlusion, followed by 24-h reperfusion. After reperfusion, the rats were killed and the brain samples were collected. Haematoxylin-eosin staining was used to evaluate the histopathological changes. Terminal deoxynucleotidyl transferase-mediated biotiny-lated UTP nick end labeling (TUNEL) and flow cytometry (FCM) analysis were used to detect the level of apoptosis. The expressions of bcl-2 and caspase-3 in the cortex were determined by Western blot. Significant increases in the number of haematoxylin-eosin- and TUNEL-positive staining cells and DNA fragmentation were observed at 24 h after reperfusion, and the increases were inhibited by breviscapine (50 and 100 mg kg(-1)). Breviscapine at both doses markedly inhibited the expression and activation of caspase-3 and up-regulated the expression of bcl-2. These findings suggested that breviscapine attenuated neuroapoptosis and regulated the protein expression related to apoptosis after transient focal cerebral ischaemia, which may have contributed, in part, to the protective effects of breviscapine on cerebral ischaemic damage.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18284815     DOI: 10.1211/jpp.60.3.0010

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  10 in total

1.  Scutellarin Alleviates Behavioral Deficits in a Mouse Model of Multiple Sclerosis, Possibly Through Protecting Neural Stem Cells.

Authors:  Wei-Wei Wang; Lin Lu; Tian-Hao Bao; Hong-Miao Zhang; Jing Yuan; Wei Miao; Shu-Fen Wang; Zhi-Cheng Xiao
Journal:  J Mol Neurosci       Date:  2015-10-29       Impact factor: 3.444

2.  Breviscapine suppresses the growth of non-small cell lung cancer by enhancing microRNA-7 expression.

Authors:  Jian Zeng; Shunv Cai
Journal:  J Biosci       Date:  2017-03       Impact factor: 1.826

3.  Role of mitofusin 2 in the protective effect of breviscapine against hepatic ischemia/reperfusion injury in rats.

Authors:  Zhen Bao; Weijun Chen; Fan Pan; Bo Peng; Jin Gong
Journal:  Exp Ther Med       Date:  2018-02-05       Impact factor: 2.447

4.  Anticancer mechanism of breviscapine in non-small cell lung cancer A549 cells acts via ROS-mediated upregulation of IGFBP4.

Authors:  Weitian Wei; Liang Wang; Liwei Xu; Jian Zeng
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

5.  Closed gateways--can neuroprotectants shield the retina in glaucoma?

Authors:  Thirumurthy Velpandian
Journal:  Drugs R D       Date:  2010

6.  Scutellarin may alleviate cognitive deficits in a mouse model of hypoxia by promoting proliferation and neuronal differentiation of neural stem cells.

Authors:  Wei-Wei Wang; Jian-Hong Han; Lin Wang; Tian-Hao Bao
Journal:  Iran J Basic Med Sci       Date:  2017-03       Impact factor: 2.699

7.  Breviscapine Pretreatment Inhibits Myocardial Inflammation and Apoptosis in Rats After Coronary Microembolization by Activating the PI3K/Akt/GSK-3β Signaling Pathway.

Authors:  Zhi-Qing Chen; You Zhou; Feng Chen; Jun-Wen Huang; Jing Zheng; Hao-Liang Li; Tao Li; Lang Li
Journal:  Drug Des Devel Ther       Date:  2021-02-25       Impact factor: 4.162

8.  Protective Effects of Scutellarin on Human Cardiac Microvascular Endothelial Cells against Hypoxia-Reoxygenation Injury and Its Possible Target-Related Proteins.

Authors:  Meina Shi; Yingting Liu; Lixing Feng; Yingbo Cui; Yajuan Chen; Peng Wang; Wenjuan Wu; Chen Chen; Xuan Liu; Weimin Yang
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-18       Impact factor: 2.629

9.  Protective effects of Erigeron breviscapus Hand.- Mazz. (EBHM) extract in retinal neurodegeneration models.

Authors:  Jingyuan Zhu; Li Chen; Yun Qi; Jing Feng; Li Zhu; Yujing Bai; Huijuan Wu
Journal:  Mol Vis       Date:  2018-04-25       Impact factor: 2.367

Review 10.  Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma.

Authors:  Annagrazia Adornetto; Laura Rombolà; Luigi Antonio Morrone; Carlo Nucci; Maria Tiziana Corasaniti; Giacinto Bagetta; Rossella Russo
Journal:  Nutrients       Date:  2020-10-16       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.